A comparative study of the antithrombotic effect of aurintricarboxylic acid on arterial thrombosis in rats and guineapigs

British Journal of Pharmacology

Volumn 118, Issue 7, 1996, Pages 1633-1638

  Takiguchi, Yoshiharu ^a,b   Shimazawa, Masamitsu ^a   Nakashima, Mitsuyoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Arterial thrombosis; Aurintricarboxylic acid; Platelet aggregation; Thrombin; Von Willebrand factor

Indexed keywords

ANTICOAGULANT AGENT; AURINTRICARBOXYLIC ACID; BOTROCETIN; GLYCOPROTEIN IB; THROMBOCYTE RECEPTOR; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; BLEEDING TIME; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMORAL ARTERY; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; THROMBOCYTE AGGREGATION;

EID: 0029901051     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15585.x     Document Type: Article

References (24)

1. BELLINGER, D.A., NICHOLS, T.C., READ, M.S., REDDICK, R.L., LAMB, M.A., BRINKHOUS, K. EVATT, B.L. & GRIGGS, T.R. (1987). Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor. Proc. Natl. Acad. Sci. U.S.A. 84, 8100-8104.
2. GIRMA, J.P., FRESSINAUD, E., CHRISTOPHE. O., ROUAULT, C., OBERT, B., TAKAHASHI, Y. & MEYER, D. (1992). Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein 1b. Thromb. Haemostas., 68, 707-713.
3. 2, ADP and thrombin in thrombogenesis in the guinea pig. Eur. J. Pharmacol., 231, 421-425.
4. HUMPHRIES, J.E., YIRINEC, B.A. & HESS, C.E. (1992). Atherosclerosis and unstable angina in Bernard-Soulier syndrome. Am. J. Clin. Pathol., 97, 652-655.
5. IKEDA, Y., HANDA, M., KAWANO, K., KAMATA, T., MURATA, M., ARAKI, Y., ANBO, H., KAWAI, Y., WATANABE, K., ITAGAKI, I., SAKAI, K. & RUGERI, Z.M. (1991). The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J. Clin. Invest., 87, 1234-1240.
6. KAWASAKI, T., KAKU, S., KOHINATA, T., SAKAI, Y., TANIUCHI, Y., KAWAMURA, K., YANO, S., TAKENAKA, T. & FUJIMURA, Y. (1994). Inhibition by aurintricarboxylic acid of von Willebrand factor binding to platelet GPlb, platelet retention and thrombus formation in vivo. Am. J. Hematol., 47, 6-15.
7. KINLOUGH-RATHBONE, R.L. & PACKHAM, M.A. (1992). Unexpected effects of aurin tricarboxylic acid on human platelets. Thromb. Haemostas., 68, 189-193.
8. KROLL, M.H., HARRIS, T.S., MOAKE, J.L., HANDIN, R.I. & SCHAFER, A.I. (1991). Von Willebrand factor binding to platelet Gplb initiates signals for platelet activation. J. Clin. Invest., 88, 1568-1573.
9. MATSUNO, H., UEMATSU, T., NAGASHIMA, S. & NAKASHIMA, M. (1991). Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model. J. Pharmacol. Methods, 25, 303-318.
10. McGHIE, A.I., MCNATT, J., EZOV, N., CUI, K., MOWER, L.K., HAGAY, Y., BUJA, L.M., GARFINKER, L.I., GORECKI, M. & WILLERSON, J.T. (1994). Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein lb binding domain. Circulation, 90, 2976-2981.
11. MOAKE, J.L., TURNER, N.A., STATHOPOULOS, N.A., NOLASCO, L. & HELLUMS, J.D. (1988). Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood, 71, 1366-1374.
12. NICHOLS, T.C., BELLINGER, D.A., JOHNSON, T.A., LAMB, M.A. & GRIGGS, T.R. (1986). von Willebrand's disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries. Circ. Res., 59, 15-26.
13. NICHOLS, T.C., BELLINGER, D.A., REDDICK, R.L., READ, M.S., KOCH, G.G., BRINKHOUS, K.M. & GRIGGS, T.R (1991). Role of von Willebrand factor in arterial thrombosis: Studies in normal and von Willebrand disease pigs. Circulation, 83, (suppl IV), IV-56-IV-64.
14. PHILLIPS, M.D., MOAKE, J.L., NOLASCO, L. & TURNER, N. (1988). Aurin tricarboxylic acid: A novel inhibitor of the association of von Willebrand factor and platelets. Blood, 72, 1898-1903.
15. RUGGERI, Z.M. & ZIMMERMAN, T.S. (1987). von Willebrand factor and von Willebrand disease. Blood, 70, 895-904.
16. SAKARIASSEN, K.S., NIEVELSTEIN, P.F.E.M., COLLER, B.S. & SIXMA, J.J. (1986). The role of platelet membrane glycoproteins lb and llb-111a in platelet adherence to human artery subendothelium. Br. J. Haematol., 63, 681-691.
17. SANIABADI, A.R., UMEMURA, K., MATSUMOTO, N., SAKUMA, S. & NAKASHIMA, M. (1995). Vessel wall injury and arterial thrombosis induced by a photochemical reaction. Thromb. Haemostas., 73, 868-872.
18. STRONY, J., PHILLIPS, M., BRANDS, D., MOAKE, J. & ADELMAN, B. (1990). Aurintricarboxylic acid in a canine model of coronary artery thrombosis. Circulation, 81, 1106-1114.
19. TAKIGUCHI, Y., ASAI, F., WADA, K., HAYASHI, H. & NAKASHIMA, M. (1995a). Antithrombotic effect of a novel recombinant hirudin analogue, CX-397, in a rat arterial thrombosis model. Br. J. Pharmacol., 116, 3056-3060.
20. 2 in reocclusion after thrombolysis. Thromb. Haemostas., 73, 683-688.
21. TAKIGUCHI, Y., HIRATA, Y., WADA, K. & NAKASHIMA, M. (1992a). Arterial thrombosis model with photochemical reaction in guinea-pig and its property. Thromb. Res., 67, 435-445.
22. 2. Thromb. Haemostas., 68, 460-463.
23. TOMITA, T., UMEGAKI, K. & HAYASHI, E. (1983). Basic properties of washed platelets: correlation between aggregation, phospholipid degradation, malondialdehyde, and thromboxane formation. J. Pharmacol. Methods, 10, 31-44.
24. YAO, S.K., OBER, J.C., GARFINKEL, L.I., HAGAY, Y., EZOV, N., FERGUSON, J.J., ANDERSON, H.V., PANET, A., GORECKI, M., BUJA, L.M. & WILLERSON, J.T. (1994). Blockade of platelet membrane glycoprotein lb receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs. Circulation, 89, 2822-2828.